Target Identification & Validation
Identify and confirm promising biological targets.
The Programme
Advancing the Future of Drug Discovery
Drug Discovery Innovation Programme (DDIP) is an invitation-only gathering for pharma, biotech, start-up companies academia, and technology leaders exploring AI, advanced biology, drug development, new modalities, and next-generation approaches to accelerate drug discovery from target identification to clinical translation.
The programme connects pioneering minds, emerging technologies, and real-world drug discovery challenges, fostering collaboration and knowledge exchange.
Our Commitment
From Discovery to Development
DDIP unites experts, technologies, and ideas across every stage of the drug discovery journey.
Hit Identification
Discover compounds that interact with the target.
Lead Discovery
Select the most promising compounds for further development.
Lead Optimization
Improve potency, selectivity, stability, and drug-like properties.
Preclinical Development
Evaluate efficacy and safety using laboratory and biological models.
IND-Enabling Studies
Complete the required safety and manufacturing studies before clinical trials.
Our Journey
13 Years. One Continuous Journey of Innovation.
A legacy of ideas, collaboration and progress — now building towards a brighter future in 2027.
2014
The Beginning
The first chapter, setting the scene for what's possible.
2018
Global Footprint
From regional discussions to a truly global platform.
2022
Stronger Together
Building a larger, more connected community.
2025
New Cities, New Ideas
Exploring new regions, new perspectives.
2026
Basel Edition
Completed chapter — a landmark edition in Basel.
Event Highlights
The Power of Being Connected
From inspiring speakers to vibrant networking — relive the key moments from our event.
01 / 06
DDIP Europe 2027
Join us in Basel
Two focused days in Basel for discovery leaders, partners, and innovators — reserve your seat, or talk to us about speaking and sponsorship.